Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

      GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

      Ruby Khatun Khatun2 July 2017 9:36 AM IST
      New Delhi: Biotech major Biocon Chairman and Managing Director Kiran Mazumdar-Shaw today cautioned of possible drug shortage after implementation of...
      FITPASS raises 1 million dollar through Abhinav Bindra

      FITPASS raises 1 million dollar through Abhinav Bindra

      Ruby Khatun Khatun1 July 2017 5:48 PM IST
      New Delhi: FITPASS, an all-access pass to gyms and fitness studios, has raised USD 1 million through India's only individual Olympic gold medallist...
      No price change in 78 percent of actively used drugs post GST: NPPA

      No price change in 78 percent of actively used drugs post GST: NPPA

      Ruby Khatun Khatun1 July 2017 4:07 PM IST
      New Delhi: Drug pricing regulator NPPA on Friday said prices of around 78 per cent of 'actively used' drugs will remain unaffected after the rollout...
      Unichem Labs gets EIR from USFDA for Goa facility

      Unichem Labs gets EIR from USFDA for Goa facility

      Ruby Khatun Khatun1 July 2017 4:07 PM IST
      New Delhi: Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulatorfor the company's plant at...
      AstraZeneca Pharma India appoints Gagan Singh Bedi as MD

      AstraZeneca Pharma India appoints Gagan Singh Bedi as MD

      Ruby Khatun Khatun1 July 2017 4:07 PM IST
      New Delhi: Drug firm AstraZeneca Pharma India on Thursday said Gagan Singh Bedi will take over as the Managing Director of the company with effect...
      Zydus Cadila gets USFDA nod to market anti-obesity drug

      Zydus Cadila gets USFDA nod to market anti-obesity drug

      Ruby Khatun Khatun1 July 2017 4:07 PM IST
      New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Phentermine Hydrochloride orally disintegrating tablets...
      Dr Harsh Vardhan launches National Biopharma Mission

      Dr Harsh Vardhan launches National Biopharma Mission

      Ruby Khatun Khatun1 July 2017 4:07 PM IST
      New Delhi: The first ever Industry-Academia mission to accelerate biopharmaceutical development in the country was formally launched by Union Science...
      Fortis Healthcare gets shareholders nod to hike FIIs shareholding limit to 74 percent

      Fortis Healthcare gets shareholders nod to hike FIIs shareholding limit to 74 percent

      Ruby Khatun Khatun30 Jun 2017 1:07 PM IST
      New Delhi: Fortis Healthcare said its shareholders have approved increasing shareholding limit for foreign institutional investors to up to 74 per...
      Eris Lifesciences shares gain 1.5% in debut trade

      Eris Lifesciences shares gain 1.5% in debut trade

      Ruby Khatun Khatun30 Jun 2017 11:45 AM IST
      New Delhi: Shares of Eris Lifesciences rose by 1.5 per cent over the issue price of Rs 603 in its debut trade today.The stock listed at Rs 612, up...
      New form of Roche

      New form of Roche's Esbriet approved in Europe for lung disorder

      Ruby Khatun Khatun30 Jun 2017 11:45 AM IST
      Roche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that...
      AstraZeneca, Chi-Med take kidney cancer drug into final testing

      AstraZeneca, Chi-Med take kidney cancer drug into final testing

      Ruby Khatun Khatun30 Jun 2017 11:45 AM IST
      AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib...
      Delhi High Court to hear pharma firms plea on fixed dose drugs ban

      Delhi High Court to hear pharma firms plea on fixed dose drugs ban

      Ruby Khatun Khatun30 Jun 2017 11:44 AM IST
      The Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok